Hb Wealth Management, LLC Nektar Therapeutics Transaction History
Hb Wealth Management, LLC
- $9.29 Billion
- Q3 2024
A detailed history of Hb Wealth Management, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Hb Wealth Management, LLC holds 44,500 shares of NKTR stock, worth $61,409. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,500Holding current value
$61,409% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NKTR
# of Institutions
141Shares Held
135MCall Options Held
32.8KPut Options Held
55.5K-
Deep Track Capital, LP Greenwich, CT17.9MShares$24.7 Million0.73% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$20.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$17.9 Million0.0% of portfolio
-
Samlyn Capital, LLC New York, NY9.46MShares$13.1 Million0.21% of portfolio
-
Eventide Asset Management, LLC Boston, MA7.53MShares$10.4 Million0.16% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $259M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...